ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,362, issued on Jan. 13, was assigned to TOKYO UNIVERSITY OF SCIENCE FOUNDATION (Tokyo).

"Agent for treating, preventing, or improving psychiatric and nervous system disorders or symptoms" was invented by Akiyoshi Saitoh (Tokyo), Yuya Terashima (Tokyo), Kouji Matsushima (Tokyo) and Yoshitake Sano (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a novel measure that is effective in therapy etc. of psychiatric or neurological disorders or symptoms, such as anxiety or depressive disorders, and is unlikely to cause problems such as dependence and adverse effects and is highly safe. The present invention provides an agent for treating, p...